| ID | Analyse | Domein | Recipiënt | Uitvoering | LTAT (uren (dagen)) | Accred. | LOINCeenheid (1) | LOINCeenheid (2) | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 4386 | Equine Herpes Virus 5 PCR EHV-5 PCR | eSwab (Wissers varia / Overig) |
2× per week | 342 (14,3) | – | – | – | › | ||
| 4749 | Equine Influenza Virus | Serum |
274 (11,4) | – | – | – | › | |||
| 4395 | Equine Influenzavirus PCR | eSwab (Wissers varia / Overig) |
2× per week | 167 (6,9) | – | – | – | › | ||
| 8497 | Equine metritis (CEM) PCR | eSwab (Wissers varia / Overig) |
– | – | – | › | ||||
| 4477 | Equine Parvovirus-Hepat. | Serum |
1× per 2 weken | – | – | – | › | |||
| 4746 | Equine viral arteritis EVA, SN antistoffen | Serum |
1× per 2 weken | 155 (6,5) | – | – | – | › | ||
| 8453 | Ernstige gecombin. IMD | EDTA |
1× per 3 weken | – | – | – | › | |||
| 71012 | Erwt f12 IgG | Serum |
2× per week, op dinsdag en vrijdag | – | – mgA/l | – | › | |||
| 1620 | Erythrocyten antistoffen Erythrocyten antistoffen - BTCA, Irreguliere antistoffen (identificatie), Rode bloedcel antistoffen - BTCA | Serum EDTA |
124 (5,2) | – | – | – | › | |||
| 21104 | Erytrocyten Erythrocyten, Erythrocytes, Erytrocyten | EDTA |
maandag t/m vrijdag | 1 (0) | B | 789-8 milj/µL | 789-8 10E12/L | › | ||
| 23050 | Erytropoëtine (EPO) EPO, Erythropoëtine | Serum |
maandag t/m vrijdag | 25 (1,1) | – | 15061-5 IU/l | – | › | ||
| ● 34302 | Estron 3-hydroxy-1,3,5(10)-estratien-17-one, E1, Estrone | Serum |
2× per week | – | 2258-2 pg/mL | 22663-9 nmol/L | › | |||
| 26310 | Ethanol Alcohol | Serum |
maandag t/m vrijdag | 2 (0,1) | – | 5643-2 g/l | – | › | ||
| 57660 | Ethanol /g creatinine | Urine |
135 (5,6) | – | – | – | › | |||
| 5913 | Ethosuximide Zarontin | Serum |
163 (6,8) | – | 3616-0 mg/l | – µmol/L | › | |||
| 57790 | Ethoxyazijnzuur/g creat. | Urine |
184 (7,7) | – | – | – | › | |||
| 5631 | Ethyleenglycol | Serum |
– | 5646-5 mg/dL | – | › | ||||
| 58035 | Ethylgluc.- Ethylsulfaat | Urine |
215 (9) | – | 93705-2 | – | › | |||
| 8035 | Ethylglucuronide | Urine |
213 (8,9) | – | – | – | › | |||
| 59251 | Ethylglucuronide haar | Haar Haar (Toxicologie / Metalen) |
569 (23,7) | – | – | – | › | |||
| 55735 | Ethylloflazepaat | Serum |
1× per week | 217 (9) | – | – ng/mL | – nmol/L | › | ||
| 57710 | Ethylmethylketon/g creat. 2 Butanone, EMK, Methylethylketon | Urine |
204 (8,5) | – | 58897-0 | – | › | |||
| 29270 | Etter-BK Mycobacterium tuberculosis cultuur | eSwab – Wondwisser / Pus / Varia |
496 (20,7) | – | 542-1 | – | › | |||
| 29250 | Etter cultuur Etter kultuur, Etter kweek | eSwab – Wondwisser / Pus / Varia |
162 (6,7) | – | – | – | › | |||
| 6007 | Everolimus Centrican | EDTA |
2× per week | 91 (3,8) | – | 50544-6 µg/l | – | › | ||
| 24732 | F.I.V. (FTLV) Feline Immunodeficiency Virus, Feline T-Lymphotropic Virus, FIV | Serum |
maandag t/m vrijdag | 11 (0,5) | – | – | – | › | ||
| 4734 | F.I.V. (Western Blot) Feline Immunodeficiency Virus, FIV | Serum |
2× per week | 213 (8,9) | – | – | – | › | ||
| 1270 | Factor II dosage | Citraat |
1× per 2 weken | – | 3289-6 % | – | › | |||
| 80821 | Factor II mutant PCR Factor II genmutatie, Factor II mutant (G20210A), Factor II variant | EDTA |
190 (7,9) | – | 24475-6 | – | › | |||
| 21286 | Factor IX (coagulans) | Citraat |
2× per week, voorzien op dinsdag en vrijdag | 82 (3,4) | – | 3187-2 % | – | › | ||
| 1272 | Factor V dosage | Citraat |
tenminste 1× per week | 218 (9,1) | – | 3193-0 % | – | › | ||
| 80810 | Factor V Leiden Factor V Leiden DNA, Factor V mutant (Leiden) | EDTA |
157 (6,5) | – | – | – | › | |||
| 80705 | Factor V mutant Factor V Leiden DNA, Factor V mutant (Leiden) | Citraat EDTA |
141 (5,9) | – | 21669-7 | – | › | |||
| 8448 | Factor VII deficientie | EDTA |
1× per 3 weken | – | – | – | › | |||
| 1274 | Factor VII dosage Proconvertine | Citraat |
1× per 2 weken | 521 (21,7) | – | 3198-9 % | – | › | ||
| 1280 | Factor VIII (dier) | Citraat |
zelden, minder dan 1× per maand | 3 (0,1) | – | – % | – | › | ||
| 1292 | Factor XI dosage | Citraat |
1× per 2 weken | 422 (17,6) | – | 3226-8 % | – | › | ||
| 1294 | Factor XII dosage Hageman Factor | Citraat |
– | 3232-6 % | – | › | ||||
| 1296 | Factor XIII screening | Citraat |
– | 3239-1 | – | › | ||||
| 4530 | Faecaal elastase hond | Faeces |
1× per week | 183 (7,6) | – | – µg/g | – | › | ||
| 29200 | Faeces cultuur Coprocultuur, Coprokultuur, Faeces kultuur | Faeces |
80 (3,3) | – | – | – | › | |||
| 2295 | Fam. hypercholesterolemie | EDTA |
17 (0,7) | – | – | – | › | |||
| 2293 | Famil.hyperlipidemie DNA apoB DNA, Familiale hypercholesterolemie, FH DNA | EDTA |
1× per 3 maanden | 221 (9,2) | – | – | – | › | ||
| 4329 | Fasciola AS | Serum |
– | – | – | › | ||||
| 4326 | Fasciola hepatica (IHA) | Serum |
1× per week | – | – | – | › | |||
| 8735 | FCoV (F.I.P.) IFT | Punctievocht (Ascites / Pleura / Pericard) |
296 (12,3) | – | – | – | › | |||
| 4418 | FCoV (FIP) virus PCR Coronavirus-titer PCR, F.I.P. PCR, Felien coronavirus PCR | Punctievocht (Ascites / Pleura / Pericard) |
maandag t/m vrijdag | 162 (6,7) | – | – | – | › | ||
| 28734 | FCoV(AS) Coronavirus-titer, F.I.P., Felien coronavirus | Punctievocht (Ascites / Pleura / Pericard) |
3× per week | 87 (3,6) | – | – | – | › | ||
| 22173 | Fe+Transferrine Ijzerverzadiging % | Serum |
1 (0,1) | – | – | – | › | |||
| ● 4778 | Fecal DX Ag Profiel | Faeces |
– | – | – | › |
